Clinical trial
Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer
NCT00463060 · Icahn School of Medicine at Mount Sinai, Other · Completed
Key facts
| NCT number | NCT00463060 |
|---|---|
| Title | Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer |
| Official title | Phase I/II Study of Stereotactic Radiation Therapy and Concurrent and Adjuvant Sutent (SU11248) as Treatment for Oligometastatic Disease |
| Lead sponsor | Icahn School of Medicine at Mount Sinai, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug, Procedure |
| Interventions | sunitinib malate (Sutent), radiotherapy |
| Enrollment | 47 |
| Start date | Jan 1, 2007 |
| Primary completion | Jul 1, 2014 |
| Completion | Jul 1, 2014 |
| First posted | Apr 19, 2007 |
| Last update posted | Jul 18, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: